In renal clear-cell carcinomas, HIF-2α activates HILPDA, which selectively enriches PUFA to promote lipid peroxidation and GPX4 inhibitor (RSL3, ML210, or ML162)-induced ferroptosis [61]. Here, EPAS1 is linked to clear cell renal carcinoma.